Grace Therapeutics, Inc.
GRCE · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$938 | -$3,362 | $636 | -$4,155 |
| Dep. & Amort. | $0 | $2 | $2 | $2 |
| Deferred Tax | $0 | $0 | -$1,018 | -$605 |
| Stock-Based Comp. | $0 | $302 | $130 | $160 |
| Change in WC | -$984 | $770 | -$66 | -$695 |
| Other Non-Cash | -$1,233 | $487 | -$2,638 | $1,178 |
| Operating Cash Flow | -$3,155 | -$1,801 | -$2,954 | -$4,115 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $15 |
| Investing Cash Flow | $0 | $0 | $0 | $15 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | -$1 | $0 | $14,999 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | -$327 | -$967 | $0 |
| Financing Cash Flow | -$1 | -$327 | $14,032 | $0 |
| Forex Effect | $12 | $0 | $0 | $0 |
| Net Chg. in Cash | -$3,143 | -$2,128 | $11,078 | -$4,100 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $20,005 | $22,133 | $11,055 | $15,155 |
| End Cash | $16,862 | $20,005 | $22,133 | $11,055 |
| Free Cash Flow | -$3,155 | -$1,801 | -$2,954 | -$4,115 |